Cytoreductive surgery for recurrent ovarian cancer

被引:9
|
作者
Hauspy, Jan [1 ]
Covens, Allan [1 ]
机构
[1] Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Obstet & Gynecol, Div Gynecol Oncol, Toronto, ON, Canada
关键词
cytoreductive surgery; recurrent ovarian cancer;
D O I
10.1097/GCO.0b013e3280115f40
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Purpose of review The issue facing clinicians managing ovarian cancer has evolved over the past three decades from treatment for cure and subsequently palliation to prolongation of survival for most patients. The purpose of this paper is to review the data, rationale, and issues surrounding cytoreductive surgery in recurrent ovarian cancer and its potential role in this new paradigm shift. Recent findings Abundant retrospective series report prolongation of survival with secondary cytoreductive surgery in recurrent ovarian cancer. Selection bias, publication bias, and subsequent therapies, however are confouding factors for survival. As management of ovarian cancer has recently evolved to a treatment of a 'chronic disease', surgery (which has a definite role in primary therapy) should be considered. Summary No prospective randomized studies have been performed to date, and therefore adoption of this method of management has been limited. The absence of good data leaves clinicians without clear direction on how to best manage patients. Patients with favorable characteristics such as a long disease free interval, good performance status, a single or few small intra-abdominal recurrences may benefit from secondary cytoreduction. A prospective randomized study is needed.
引用
收藏
页码:15 / 21
页数:7
相关论文
共 50 条
  • [11] Cytoreductive surgery combined with HIPEC in newly diagnosed and recurrent ovarian cancer
    Tentes, A. A. K.
    Palaskas, T. B.
    Stamou, K.
    Stoforos, C. E.
    Pallas, N.
    Karamveri, C.
    Kyziridis, D.
    Hristakis, C.
    Kyriakopoulos, V
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2019, 40 (01) : 48 - 54
  • [12] Cytoreductive surgery for ovarian cancer
    Kecmanovic, DM
    Pavlov, MJ
    Kovacevic, PA
    Ceranic, MS
    Stamenkovic, AB
    EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 2003, 29 (04): : 315 - 320
  • [13] Exploring the Survival Determinants in Recurrent Ovarian Cancer: The Role of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
    Geca, Katarzyna
    Litwinski, Jakub
    Ostrowski, Tomasz
    Swietlicka, Izabela
    Polkowski, Wojciech P.
    Skorzewska, Magdalena
    CANCERS, 2024, 16 (11)
  • [14] Tertiary cytoreductive surgery in recurrent ovarian cancer: Selection criteria and survival outcome
    Karam, Amer K.
    Santillan, Antonio
    Bristow, Robert E.
    Giuntoli, Robert, II
    Gardner, Ginger J.
    Cass, Ilana
    Karlan, Beth Y.
    Li, Andrew J.
    GYNECOLOGIC ONCOLOGY, 2007, 104 (02) : 377 - 380
  • [15] Hepatic resection during cytoreductive surgery for primary or recurrent epithelial ovarian cancer
    Maria Luisa Gasparri
    Giovanni Grandi
    Daniele Bolla
    Beat Gloor
    Sara Imboden
    Pierluigi Benedetti Panici
    Michael D. Mueller
    Andrea Papadia
    Journal of Cancer Research and Clinical Oncology, 2016, 142 : 1509 - 1520
  • [16] Secondary cytoreductive surgery with and without hyperthermic intraperitoneal chemotherapy for recurrent ovarian cancer
    Lee, Dowon
    Lee, Jinhye
    Park, Hyemin
    Lee, Yong Jae
    Lee, Jung-Yun
    Nam, Eun Ji
    Kim, Sang Wun
    Kim, Sunghoon
    Kim, Young Tae
    GLAND SURGERY, 2023, 12 (12) : 1696 - 1704
  • [17] Secondary cytoreductive surgery in patients with platinum-sensitive recurrent ovarian cancer
    Panici, Pierluigi Benedetti
    De Vivo, Antonio
    Bellati, Filippo
    Manci, Natalina
    Perniola, Giorgia
    Basile, Stefano
    Muzii, Ludovico
    Angioli, Roberto
    ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (03) : 1136 - 1142
  • [18] Secondary Cytoreductive Surgery in Patients with Platinum-Sensitive Recurrent Ovarian Cancer
    Pierluigi Benedetti Panici
    Antonio De Vivo
    Filippo Bellati
    Natalina Manci
    Giorgia Perniola
    Stefano Basile
    Ludovico Muzii
    Roberto Angioli
    Annals of Surgical Oncology, 2007, 14 : 1136 - 1142
  • [19] Prognostic factors of secondary cytoreductive surgery for patients with recurrent epithelial ovarian cancer
    Bae, Jaeman
    Lim, Myong Cheol
    Choi, Jae-Ho
    Song, Yong-Joong
    Lee, Kyoung-Soo
    Kang, Sokbom
    Seo, Sang-Soo
    Park, Sang-Yoon
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2009, 20 (02) : 101 - 106
  • [20] Hepatic resection during cytoreductive surgery for primary or recurrent epithelial ovarian cancer
    Gasparri, Maria Luisa
    Grandi, Giovanni
    Bolla, Daniele
    Gloor, Beat
    Imboden, Sara
    Panici, Pierluigi Benedetti
    Mueller, Michael D.
    Papadia, Andrea
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2016, 142 (07) : 1509 - 1520